作者: Judy Trivits Verger , Emily Elizabeth Verger
DOI: 10.1016/J.CCELL.2012.07.008
关键词:
摘要: Respiratory syncytial virus is a highly infectious that commonly causes bronchiolitis and leads to high morbidity low, but important, incidence of mortality. Supportive therapy the foundation management. Hydration/nutrition respiratory support are important evidence-based interventions. For children with severe disease, continuous positive airway pressure or mechanical ventilation may be necessary. Ribavirin used for treatment patients disease. Palivizumab provides ongoing immunoprophylaxis during epidemic months high-risk infants. Caregiver education incorporating an explanation all therapies anticipatory guidance, including strategies reducing risk infection, vital.